ZILRETTA™ for Treatment of Idiopathic Adhesive Capsulitis
Status:
Recruiting
Trial end date:
2023-12-31
Target enrollment:
Participant gender:
Summary
Adhesive capsulitis is a fairly common orthopedic condition that causes pain and loss of
range of motion. There are a variety of ways to treat adhesive capsulitis, one of them being
an intra-articular steroid injection. This is done to help decrease the inflammatory response
caused by adhesive capsulitis. In this study, all participants will receive an
intra-articular glenohumeral injection of ZILRETTA and will be followed up with at four time
points over 1 year to observe pain, function and range of motion following the injection.